Q9996 Ustekinumab- ttwe sub cu injection
Also known as: ustekinumab, IL-12/23 inhibitor, Stelara
Injection of ustekinumab-ttwe (Stelara), a TNF-alpha antagonist administered subcutaneously.
In Plain Language
psoriasis injection; immune blocker; autoimmune treatment
Clinical Context
Used for plaque psoriasis, psoriatic arthritis, and inflammatory bowel disease. Administered subcutaneously on a specific dosing schedule.
RVU Information
CPT Q9996 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Q-codes are temporary HCPCS codes used when no permanent code exists. Coverage and reimbursement vary by payer and region. Document the clinical indication and medical necessity. These codes may be replaced by permanent codes in future HCPCS updates.
Specialties
Frequently Asked Questions
What is CPT code Q9996?
CPT Q9996 (Ustekinumab- ttwe sub cu injection) is a Q Codes code. Injection of ustekinumab-ttwe (Stelara), a TNF-alpha antagonist administered subcutaneously.
Is Q9996 covered by insurance?
Q9996 is a temporary HCPCS code. Coverage varies by payer and may change when permanent codes are assigned. Used for plaque psoriasis, psoriatic arthritis, and inflammatory bowel disease. Administered subcutaneously on a specific dosing schedule.
When is CPT Q9996 used?
Used for plaque psoriasis, psoriatic arthritis, and inflammatory bowel disease. Administered subcutaneously on a specific dosing schedule.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.